Michael Phillips

Michael Phillips

Auto-generated profile, based on publicly available information

Michael Phillips

Menssana Research Inc, 1 Horizon Road, Suite 1415, Fort Lee, NJ 07024, United States of America. Department of Medicine, New York Medical College, Valhalla, NY, United States of America

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2005 in JAMA
Verified
Journal Article
Closed access
PDF file
JMJ. John Mann
J. John Mann
AAAlan Apter
Alan Apter
JBJose Bertolote
Jose Bertolote
ABAnnette Beautrais
Annette Beautrais
DCDianne Currier
Dianne Currier
HHHerbert Hendin
Herbert Hendin
ContextIn 2002, an estimated 877 000 lives were lost worldwide through suicide. Some developed nations have implemented national suicide prevention plans. Although these plans generally propose multiple interventions, their effectiveness is rarely evaluated.ObjectivesTo examine evidence for the effectiveness of specific suicide-preventive interventions and to make recommendations for future prevention programs and research.Data Sources and Study SelectionRelevant publications were identified via electronic searches of MEDLINE, the Cochrane Library, and PsychINFO databases using multiple search terms related to suicide prevention. Studies, published between 1966 and June 2005, included those that evaluated preventative interventions in major domains; education and awareness for the general public and for professionals; screening tools for at-risk individuals; treatment of psychiatric disorders; restricting access to lethal means; and responsible media reporting of suicide.Data ExtractionData were extracted on primary outcomes of interest: suicidal behavior (completion, attempt, ideation), intermediary or secondary outcomes (treatment seeking, identification of at-risk individuals, antidepressant prescription/use rates, referrals), or both. Experts from 15 countries reviewed all studies. Included articles were those that reported on completed and attempted suicide and suicidal ideation; or, where applicable, intermediate outcomes, including help-seeking behavior, identification of at-risk individuals, entry into treatment, and antidepressant prescription rates. We included 3 major types of studies for which the research question was clearly defined: systematic reviews and meta-analyses (n = 10); quantitative studies, either randomized controlled trials (n = 18) or cohort studies (n = 24); and ecological, or population- based studies (n = 41). Heterogeneity of study populations and methodology did not permit formal meta-analysis; thus, a narrative synthesis is presented.Data SynthesisEducation of physicians and restricting access to lethal means were found to prevent suicide. Other methods including public education, screening programs, and media education need more testing.ConclusionsPhysician education in depression recognition and treatment and restricting access to lethal methods reduce suicide rates. Other interventions need more evidence of efficacy. Ascertaining which components of suicide prevention programs are effective in reducing rates of suicide and suicide attempt is essential in order to optimize use of limited resources.

9 April 2020 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
JLJennifer Lighter
Jennifer Lighter
MPMichael Phillips
Michael Phillips
SHSarah E. Hochman
Sarah E. Hochman
SSStephanie Sterling
Stephanie Sterling
DJDiane Johnson
Diane Johnson
ASAnna Stachel
Anna Stachel

1 October 2002 in Emerging Infectious Diseases
Verified
Journal Article
Open access
DJDaniel B. Jernigan
Daniel B. Jernigan
PRPratima L. Raghunathan
Pratima L. Raghunathan
BBBeth P. Bell
Beth P. Bell
RBRoss Brechner
Ross Brechner
EBEddy A. Bresnitz
Eddy A. Bresnitz
JGJulie L. Gerberding
Julie L. Gerberding
In October 2001, the first inhalational anthrax case in the United States since 1976 was identified in a media company worker in Florida. A national investigation was initiated to identify additional cases and determine possible exposures to Bacillus anthracis. Surveillance was enhanced through health-care facilities, laboratories, and other means to identify cases, which were defined as clinically compatible illness with laboratory-confirmed B. anthracis infection. From October 4 to November 20, 2001, 22 cases of anthrax (11 inhalational, 11 cutaneous) were identified; 5 of the inhalational cases were fatal. Twenty (91%) case-patients were either mail handlers or were exposed to worksites where contaminated mail was processed or received. B. anthracis isolates from four powder-containing envelopes, 17 specimens from patients, and 106 environmental samples were indistinguishable by molecular subtyping. Illness and death occurred not only at targeted worksites, but also along the path of mail and in other settings. Continued vigilance for cases is needed among health-care providers and members of the public health and law enforcement communities.

1 January 2007 in Tuberculosis
Verified
Journal Article
Closed access
MPMichael Phillips
Michael Phillips
RCRenee N. Cataneo
Renee N. Cataneo
RCRany Condos
Rany Condos
GEGerald A. Ring Erickson
Gerald A. Ring Erickson
JGJoel Greenberg
Joel Greenberg
OTOlaf Tietje
Olaf Tietje

25 April 2007 in Cancer Biomarkers
Verified
Journal Article
Closed access
PDF file
MPMichael Phillips
Michael Phillips
NANasser Altorki
Nasser Altorki
JAJohn H.M. Austin
John H.M. Austin
RCRobert B. Cameron
Robert B. Cameron
RCRenee N. Cataneo
Renee N. Cataneo
PSPeter Schmitt
Peter Schmitt
Background: Normal metabolism generates several volatile organic compounds (VOCs) that are excreted in the breath (e.g. alkanes). In patients with lung cancer, induction of high-risk cytochrome p450 genotypes may accelerate catabolism of these VOCs,

1 January 2011 in Southern Medical Journal
Verified
Journal Article
Closed access
RARyan S. Arnold
Ryan S. Arnold
KTKerri A. Thom
Kerri A. Thom
SSSaarika Sharma
Saarika Sharma
MPMichael Phillips
Michael Phillips
JJJ. Kristie Johnson
J. Kristie Johnson
DMDaniel J. Morgan
Daniel J. Morgan
Klebsiella pneumoniae carbapenemase (KPC)-producing bacteria are a group of emerging highly drug-resistant Gram-negative bacilli causing infections associated with significant morbidity and mortality. Once confined to outbreaks in the northeastern United States (US), they have spread throughout the US and most of the world. KPCs are an important mechanism of resistance for an increasingly wide...